Menopause/NN
is/VBZ
associated/VBN
with/IN
a/DT
significant/JJ
increase/NN
in/IN
blood/NN
monocyte/NN
number/NN
and/CC
a/DT
relative/JJ
decrease/NN
in/IN
the/DT
expression/NN
of/IN
estrogen/NN
receptors/NNS
in/IN
human/JJ
peripheral/JJ
monocytes/NNS
./.

PROBLEM/NN
:/:
The/DT
clinical/JJ
significance/NN
of/IN
the/DT
differential/JJ
expression/NN
of/IN
estrogen/NN
receptor/NN
(/(
ER/NN
)/)
in/IN
human/JJ
monocytes/NNS
was/VBD
evaluated/VBN
./.
=====
METHOD/NN
:/:
Two/CD
color/NN
flow/NN
cytometry/NN
analysis/NN
was/VBD
used/VBN
on/IN
peripheral/JJ
blood/NN
samples/NNS
of/IN
young/JJ
and/CC
postmenopausal/JJ
females/NNS
and/CC
postmenopausal/JJ
females/NNS
treated/VBN
with/IN
estrogen/NN
replacement/NN
therapy/NN
./.
=====
In/IN
addition/NN
,/,
the/DT
monocyte/NN
and/CC
lymphocyte/NN
counts/NNS
and/CC
the/DT
blood/NN
estrogen/NN
levels/NNS
of/IN
each/DT
patient/NN
were/VBD
determine/VBN
./.
=====
RESULTS/NNS
:/:
During/IN
menopause/NN
there/EX
is/VBZ
a/DT
significant/JJ
decrease/NN
in/IN
the/DT
percentage/NN
of/IN
ER/NN
positive/JJ
monocytes/NNS
,/,
and/CC
an/DT
increase/NN
in/IN
blood/NN
monocyte/NN
number/NN
,/,
which/WDT
declines/VBZ
following/VBG
estrogen/NN
replacement/NN
therapy/NN
to/TO
values/NNS
of/IN
the/DT
young/JJ
./.
=====
CONCLUSIONS/NNS
:/:
These/DT
findings/NNS
suggest/VBP
that/IN
estrogen/NN
modulates/VBZ
the/DT
monocyte/NN
numbers/NNS
and/CC
its/PRP$
effects/NNS
may/MD
be/VB
mediated/VBN
through/IN
the/DT
ER/NN
in/IN
the/DT
monocytes/NNS
./.